Metronidazole

Generic Name
Metronidazole
Brand Names
Flagyl, Flagystatin, Likmez, Metrocream, Metrogel, Metrolotion, Nidagel, Noritate, Nuvessa, Pylera, Rosadan, Vandazole
Drug Type
Small Molecule
Chemical Formula
C6H9N3O3
CAS Number
443-48-1
Unique Ingredient Identifier
140QMO216E
Background

Metronidazole is a commonly used antibiotic, belonging to the nitroimidazole class of antibiotics. It is frequently used to treat gastrointestinal infections as well as trichomoniasis and giardiasis, and amebiasis which are parasitic infections. Metronidazole has been used as an antibiotic for several decades, with added antiparasitic properties that set it ...

Indication

Metronidazole is indicated for the treatment of confirmed trichomoniasis caused by Trichomonas vaginalis (except for in the first trimester of pregnancy) and the patient's sexual partners, bacterial vaginosis, certain types of amebiasis, and various anaerobic infections. The above anaerobic infections may occur on the skin and skin structures, the abdomen, t...

Associated Conditions
Abscess Brain, Abscess, Intra-Abdominal, Anaerobic Bacterial Infection, Bacterial Endocarditis, Bacterial Peritonitis, Bacterial Septicemia, Bacterial Vaginosis (BV), Balantidiasis, Bone and Joint Infections, Central Nervous System Bacterial Infections, Empyema, Endometritis, Endomyometritis, Facial Rosacea, Giardiasis, Gynecological Infection, Helicobacter Pylori Infection, Inflammatory Papule, Inflammatory pustules, Liver Abscess, Amebic, Lower respiratory tract infection bacterial, Lung Abscess, Meningitis, Mixed Vaginal Infections, Mixed Vaginal Infections caused by Trichomonas Vaginalis, candida albicans, Periodontitis, Pneumonia, Postoperative Infections, Pouchitis, Skin and skin structure infections, Tetanus, Trichomonas Vaginitis, Tubo-ovarian abscess, Vaginal Candidiasis, Vaginitis Trichomonal, Vulvovaginitis, Acute Intestinal amebiasis, Asymptomatic Trichomoniasis, Entamoeba histolytica, Hepatic abscess, Intra-abdominal bacterial infections, Post-surgical vaginal cuff infection, Refractory Sinusitis, Symptomatic Trichomoniasis
Associated Therapies
-

Bacterial Vaginosis Home Screening to Prevent STDs

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-04-28
Last Posted Date
2020-02-18
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
1370
Registration Number
NCT00667368
Locations
🇺🇸

University of North Carolina School of Medicine - Center for Infectious Diseases, Chapel Hill, North Carolina, United States

🇺🇸

Johns Hopkins Bayview Medical Center - Infectious Diseases, Baltimore, Maryland, United States

🇺🇸

San Francisco Department of Public Health - San Francisco City Clinic, San Francisco, California, United States

and more 4 locations

Antimicrobial PK in Infants With Suspected or Confirmed Infection

First Posted Date
2007-06-26
Last Posted Date
2012-11-19
Lead Sponsor
Duke University
Target Recruit Count
450
Registration Number
NCT00491426
Locations
🇺🇸

Children's National Medical Center, Washington, District of Columbia, United States

🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

🇺🇸

University of California at San Diego, La Jolla, California, United States

and more 3 locations

Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study

Phase 4
Completed
Conditions
Interventions
First Posted Date
2007-04-23
Last Posted Date
2017-05-11
Lead Sponsor
University of Pittsburgh
Target Recruit Count
12
Registration Number
NCT00464542
Locations
🇺🇸

University of Pittsburgh, Pittsburgh, Pennsylvania, United States

🇺🇸

University of Pittsburgh, Magee Womens Hospital, Pittsburgh, Pennsylvania, United States

Malabsorption as a Cause of Iron Treatment Failure in Infants

Not Applicable
Completed
Conditions
First Posted Date
2007-04-05
Last Posted Date
2007-04-05
Lead Sponsor
HaEmek Medical Center, Israel
Target Recruit Count
100
Registration Number
NCT00456729
Locations
🇮🇱

Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center, Afula, Israel

Metronidazole for Pulmonary Tuberculosis (South Korea)

First Posted Date
2007-01-22
Last Posted Date
2013-07-10
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
35
Registration Number
NCT00425113
Locations
🇰🇷

National Masan Tuberculosis Hospital, Masan, Korea, Republic of

🇰🇷

Yonsei University College of Medicine, Seoul, Korea, Republic of

Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis

Phase 2
Completed
Conditions
First Posted Date
2007-01-04
Last Posted Date
2007-01-04
Lead Sponsor
Romark Laboratories L.C.
Target Recruit Count
114
Registration Number
NCT00417872
Locations
🇺🇸

WellStar Infectious Diseases, Marietta, Georgia, United States

🇺🇸

The Reading Hospital and Medical Center, West Reading, Pennsylvania, United States

🇺🇸

Remington-Davis, Inc., and Riverside Infection Consultants, Inc., Columbus, Ohio, United States

and more 4 locations

Antibiotics for the Treatment of Ulcerative Colitis

Not Applicable
Completed
Conditions
First Posted Date
2006-07-24
Last Posted Date
2009-02-11
Lead Sponsor
University of Dundee
Target Recruit Count
40
Registration Number
NCT00355602
Locations
🇬🇧

Ninewells Hospital and Medical School, Dundee, Angus, United Kingdom

EFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth

First Posted Date
2006-05-31
Last Posted Date
2009-07-20
Lead Sponsor
Sanofi
Target Recruit Count
250
Registration Number
NCT00331994
Locations
🇮🇹

Sanofi-Aventis Administrative Office, Milan, Italy

Response of Clostridium Difficile Infection to Metronidazole Therapy

First Posted Date
2006-03-17
Last Posted Date
2013-02-18
Lead Sponsor
Michael E. DeBakey VA Medical Center
Target Recruit Count
290
Registration Number
NCT00304369
Locations
🇺🇸

Michael E. Debakey VA Medical Center, Houston, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath